Table 4.

Elements of Organised Screening that have been Implemented

		Albania	Armenia	Azerbaijan	Belarus	Bosnia and Herzegovina Republika Srpska		Georgia Ex Tbilisi	Kazakhstan	Kosovo	Kyrgyzstan	Moldova	North Macedonia	Serbia	Tajikistan	Turkey	Turkmenistan	Ukraine	Uzbekistan
Central administrative unita		Yes	No	No	Yes	No	No	Yes	Yes	No	No	Yes	Yes	Yes	No	Yes	No	No	No
Central access to population datab		No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	No
Recruitmentc		Loc	Loc	Opp	Opp	Opp	Loc	Loc	Loc	Loc, Opp	Opp	Loc	Loc	Loc, Opp	Opp	Loc	Loc	Opp	Loc
Data recordingd		ii,v	iii,v	iv	v	iii,iv	iii,iv	i,v	iii,iv	iii,v	v	iii,iv	ii,v	iii,iv	v	iii,iv	iii,iv	iii,v	iii,v
Cancer registrye		Nat	Imp	Nat	Nat	Reg	Reg	Nat	Nat	Nat	Reg	Nat	Nat	Nat	Nat	Nat	Nat	Nat	Nat
Member of the:	IACR	Yes	No	Yes	Yes	No	Yes	Yes	Yes	No	Yes	Yes	No	Yes	No	Yes	No	Yes	No
	ENCR	No	No	No	Yes	No	Yes	No	No	No	No	No	No	Yes	No	No	No	Yes	No
Central access to a cancer registryf		No	No	No	No	No	No	Yes	No	No	No	No	No	No	No	No	No	No	No
QAg		Yes	No	No	No	No	No	No	Yes	No	No	No	No	Yes	No	No	No	No	No
Screening guidelinesh - year		Yes	Yes	No	No	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	No	No	Yes	No	Yes	No
		2019	2014			2008	2003	2010	2012	2018	2015	2020				2017		2014
Clinical protocols colposcopyi - year		Yes	Yes	No	No	No	No	Yes	Yes	Yes	Yes	Yes	No	Yes	No	Yes	Yes 2014	Yes	Yes
		2019	2014					2010	2012	2018	2020	2020		2013		2017		2014	2019

a, Central administrative unit: a central (national/regional/municipal) administrative unit with official responsibility for coordinating the screening process; b, Central access to population data: the central administrative unit has access to a current database that could be used to characterise the target population with sufficient detail so women who should be screened can be identified and invited; c, Recruitment: Loc = the local screening providers identify the women who should be screened from their lists of the attached populations and invite them; Opp = women are screened opportunistically upon their own request or when they are attending the health care provider for other reasons; d, Data recording ; i. Central recording of ID details for each woman screened together with her screening test results and follow-up procedures; ii. Central recording of ID details for each woman screened together with her screening test results but not monitoring the follow-up/treatment of screen-positive women; iii. Central recording of the number of screening tests but not linked to any ID details; iv. Provider level recording of ID for each woman screened together with her screening test results and follow-up procedures; v. Provider level recording of ID details for each woman screened together with her screening test results but not monitoring the follow-up/treatment of screen-positive women.; e, Cancer registry: Nat = national; Reg = regional; Imp = implementing; f, Central access to a cancer registry: the central administrative unit has access to a population-based cancer registry for QA and audit; g, QA system: a centrally managed QA system covering the cervical screening process; h, Screening guidelines: guidelines for the entire screening process describing the roles of all the component services as well as the interaction between them; i., Colposcopy clinical protocols: protocols describing the management of screen-positive women based on their screening and/or follow-up test results, as well as the clinical procedures that are required at each step in the process.